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Human  enterovirus  71 (EV71)  is  a primary  etiological  agent  of  hand,  foot,  and mouth  disease  (HFMD).  The
associated  infections  have  posed  a serious  threat  to  the public  health.  In the  present  study,  a  real-time
simultaneous  ampliﬁcation  and testing  (SAT)  technology  was  developed  for detecting  EV71  (SAT-EV71).
The  RNA  of  EV71  and  an  internal  control  (IC)  were  ampliﬁed  and analyzed  simultaneously  by  isothermal
ampliﬁcation  and  real-time  detection  of  ﬂuorescence  using  routine  real-time  PCR.  Furthermore,  this
SAT-EV71  method  with  IC was  evaluated  by analyzing  256  clinical  specimens  including  60  enterovirus-
positive  ones  conﬁrmed  by the virus-cell  culture  method.  The  other  196 putative  ones  were  furthernterovirus 71
sothermal ampliﬁcation
CR-ﬂuorescence probing assay
analyzed  by a  PCR-ﬂuorescence  probing  assay.  The  results  showed  that  SAT-EV71  can  detect  the  EV71
VP1  with  a minimum  of 10 copies  per  reaction  at  an  optimal  concentration  of  IC (5000  copies  per  reaction)
with  a high  sensitivity  and  speciﬁcity.  Meanwhile,  the  use  of  IC  can prevent  false  negatives  effectively
by  monitoring  the  processes  of nucleic  acid extraction  and  ampliﬁcation.  Overall,  this easy-to-perform
SAT-EV71  with  IC can  detect  EV71  sensitively  and  speciﬁcally.  It might  be used  in  the  molecular  diagnosis
of  EV71  in  putative  cases  of  HFMD.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.. Introduction
Enterovirus 71 (EV71) is one of the major etiologic agents of
and, foot, and mouth disease (HFMD) (Schmidt et al., 1974),
elonging to human enterovirus A, within the genus Enterovirus
nd the family of Picornaviridae. To date, EV71 has caused large-
cale outbreaks of HFMD with high mortality rates in European
nd Asian countries and regions including Bulgaria, Hungary, Japan,
aiwan, Singapore, Malaysia, China, and Thailand since the mid
970s. (Nagy et al., 1982; Chumakov et al., 1979; Hosoya et al., 2006;
hen et al., 2007; Ang et al., 2009; Yang et al., 2009; Chua and Kasri,
011; De et al., 2011; Puenpa et al., 2011). Previous reports have
hown that the prevalence of EV71 infection has increased substan-
ially since 1997 in the Asia-Paciﬁc region. Experts expected this
rend to continue (Yang et al., 2009). This virus is associated with
∗ Corresponding author. Tel.: +86 013851891090.
E-mail address: chenqian97@163.com (Q. Chen).
166-0934 © 2013 The Authors. Published by Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.jviromet.2013.11.003
Open access under CC BY-NC-NDacute neurological diseases, such as encephalitis, poliomyelitis-like
paralysis, and aseptic meningitis. The associated deaths have drawn
much attention to the public health threat. There is considerable
demand for rapid and reliable methods of detecting EV71, which
would allow physicians to treat infected patients in a timely man-
ner and prevent the spread of HFMD.
The isolation of EV71 is the gold standard for deﬁnitive diagno-
sis of HFMD; however this technique may  not be practical during
outbreaks due to the limited sensitivity and the required growth
period which lasts for weeks. Serological testing of paired acute-
and convalescent-phase serum samples is the foundation of EV71
diagnosis. Unfortunately, this approach can only be used to conﬁrm
EV71 infection after patients recover. Currently, nucleic acid ampli-
ﬁcation techniques such as conventional reverse transcription PCR
(RT-PCR) (Hosoya et al., 2006; Yang et al., 2009; De et al., 2011;
Puenpa et al., 2011), real-time RT-PCR (Tan et al., 2008, 2012), and
reverse transcription loop-mediated isothermal ampliﬁcation (RT-
LAMP) (Jiang et al., 2011; Shi et al., 2011; Xia et al., 2011; Wang et al.,
2012; Yaqing et al., 2012) are the most common means of detecting
EV71. These methods are reasonably sensitive. However, they have
certain shortcomings. For example, conventional RT-PCR needs gel
electrophoresis which takes 3 h even under ideal conditions and
involves a signiﬁcant risk of cross-contamination. Real-time PCR
 license.
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Table 1
Prime, probe and IC-RNA sequences.
Primer Sequence
Forward
primer
5′-
AATTTAATACGACTCACTATAGGGAGATCTCCAACTARACCCGCYCTGCT
-3′ (Y = C/T, R = A/G)
Reverse
primer
5′-GCACTCCAAGCTGCTGAAATTG-3′
Probe 5′-CCUCAAAUGCUAGUGAGG-3′
IC-
probe
5′-CCGACGUGAUACGAGAGAGUCGG-3′40 Q. Chen et al. / Journal of Virolo
s faster, but it requires speciﬁc laboratory facilities and skilled
echnicians. Performance was therefore limited (Jiang et al., 2011).
sothermal ampliﬁcation technology, such as RT-LAMP can be used
o detect many types of pathogens, including RNA viruses (Dukes
t al., 2006; Arita et al., 2009; Kubo et al., 2010). The detection of
V71 using RT-LAMP is easy and takes only about 60 min. However,
he RT-LAMP products of EV71 must be identiﬁed either through
isual assessment of changes in sample turbidity or in sample ﬂu-
rescence under normal or UV light, which can be very subjective;
r through gel electrophoresis, which requires considerable time
Jiang et al., 2011; Shi et al., 2011; Xia et al., 2011; Wang et al., 2012;
aqing et al., 2012). Like RT-PCR, RT-LAMP technique involves some
isk of cross-contamination.
To overcome the shortcomings, a new method of simulta-
eous ampliﬁcation testing (SAT) was developed for detecting
V71 (SAT-EV71). This method was based on isothermal ampli-
cation of RNA and real-time detection of ﬂuorescence which
as ﬁrstly established to detect Mycobacterium tuberculosis com-
lex (SAT-TB) rapidly, sensitively and speciﬁcally by Cui et al.
2012). An internal control (IC) was also added in the system to
onﬁrm the success of extraction and ampliﬁcation. In addition,
he SAT-EV71 was evaluated by detecting EV71 in 256 clinical
pecimens.
. Materials and methods
.1. Clinical samples
A total of 196 throat swabs were obtained from 196 putative
FMD patients registered at Nanjing Children’s Hospital afﬁliated
o Nanjing Medical University within 2–7 days of infection. Addi-
ionally, 60 throat swabs identiﬁed as EV71 or CA16 positive by
irus-cell culture method were provided by Nanjing Center for Dis-
ase Control and Prevention. All the study participants, or their legal
uardians, provided written informed consent. The study proto-
ol was approved by the ethics committee of Nanjing Children’s
ospital. Within 1 h of collection, the specimens were added to
 ml  of sterile physiological saline and then frozen at −80 ◦C for
urther analysis. Viral nucleic acid of EV71 (genotype C4), coxsack-
evirus A16 (CVA16), CVA4, CVA11, coxsackievirus B2 (CVB2), CVB3,
chovirus 9 (ECHO9), ECHO11, poliovirus type 1 (PV1), rubella
irus (RV), measles virus (MV), and adenovirus (ADV) were used
s positive and negative controls in evaluation of the speciﬁcity of
AT-EV71. All viral strains involved in the present study were iso-
ated and preserved in Jiangsu Province Center for Disease Control
nd Prevention. Total RNA of these viruses and 256 throat swabs
ere extracted using a QIAamp Viral RNA Mini Kit (Qiagen, Hilden,
ermany) in accordance with the manufacturer’s instructions. The
NA was suspended in a ﬁnal volume of 60 l elution buffer and
ept at −80 ◦C until use.
.2. Primers, probes, and IC for SAT-EV71
The VP1 gene of EV71 virus, which is highly conserved, has been
sed to distinguish enterovirus serotypes by many previous studies
Tan et al., 2008, 2012; Xia et al., 2011; Wang et al., 2012; Yaqing
t al., 2012). The VP1 sequence of EV71 strain (EV71/Jinan1002,
enBank accession number JQ074187.1) was obtained from the
enBank database and used in the design of primers and probes
or SAT-EV71 using DNASTAR software (Fig. 1). The primers were
esigned to amplify a 140 bp fragment. The forward primer con-
ained the T7 promoter sequence (Table 1). The probe was  labeled
ith FAM at the 5′ end and with quencher DABCYL at the 3′ end.
he IC-probe sequence was labeled with HEX at the 5′ end and
ith DABCYL at the 3′ end. The feasibility of the primers andprobes was validated by BLAST analysis on NCBI. This also ruled
out possible cross-reactions with enteroviruses other than EV71.
The 350 bp in vitro transcribed RNA product containing the 140 bp
EV71 VP1 ampliﬁcation target was synthesized by Invitrogen Cor-
poration (Shanghai, China). Transcribed RNA served as a positive
control and was used to estimate the technical sensitivity of SAT-
EV71. The IC RNA used in this assay was designed to be identical
to the 350 bp sequence of positive control RNA, differing only in
that the EV71 probe binding sequences in the positive control RNA
were replaced with IC-probe binding sequences. The IC contained
primer sequences speciﬁc to EV71, which was  also synthesized by
Invitrogen Corporation (Shanghai, China).
2.3. SAT-EV71 assay
Conditions for SAT-EV71, such as the optimal concentration of
primers and probes, were determined to acquire the best ampliﬁca-
tion efﬁciency of SAT-EV71. A series of concentration of IC (between
105 and 101 copies per reaction) and EV71 RNA (between 105 and
101 copies per reaction) were added into the reaction system and
tested to determine the optimal amount of IC. Finally, 5000 copies
of the IC were determined. This amount of IC not only exerted little
interference on the target EV71 RNA and guaranteed the sensitiv-
ity of SAT-EV71, but also took the availability and repeatability
of IC into consideration. Brieﬂy, a total volume of 30 l reaction
solution mainly containing 5 pM each of the forward primer, the
probe, and IC-probe, 2.5 pM of the reverse primer was incubated
with 2 l extracted EV71 RNA (the same amount used in PCR-
ﬂuorescence probing assay) was placed in a 200-l PCR tube and
kept at 60 ◦C for 10 min. The temperature was then reduced to 42 ◦C
for 5 min. Then a 10-l enzyme solution containing 2000 units
of Moloney murine leukemia virus (M-MLV) reverse transcriptase
and 2000 units of T7 RNA polymerase (RD Bioscience Corporation,
Shanghai, China) was  added to each tube, and the contents were
gently mixed. RNA isothermal ampliﬁcation was conducted at 42 ◦C
for 1 min, with 60 cycles. FAM and VIC ﬂuorescence data were col-
lected after each ampliﬁcation cycle. Ampliﬁcation and detection
were carried out in a 7500 real-time PCR system (Applied Biosys-
tems Corporation, USA). Specimens with FAM cycle thresholds
(Ct) values ≤ 55 were considered EV71-positive regardless of the
results of IC. Specimens with FAM Ct values > 55 or lacking data and
that also with VIC Ct values ≤ 55 were classiﬁed as EV71-ngative.
Specimens lacking FAM and VIC data were classiﬁed as inhibitory.
Inhibitory specimens were retested using another aliquot of the
original specimen. Care was  taken to avoid contamination. The
tests were performed in a biological safety cabinet (Thermo 1389
A2, ThermoFisher scientiﬁc, Ohio, USA) in a bio-safe PII laboratory.
Each test included no-template controls to permit monitoring of
the nonspeciﬁc ampliﬁcation products and the presence of con-
tamination.
Q. Chen et al. / Journal of Virological Methods 196 (2014) 139– 144 141
Fig. 1. Comparison of the nucleotide sequences of EV71 and CA16 genomes on the VP1 region examined for the SAT-EV71 primers and probe. Genomic sequences of the
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.4. Sensitivity, speciﬁcity, repeatability and reproducibility of
he SAT-EV71
An assessment of technical sensitivity of SAT-EV71 was  imple-
ented using quantiﬁed RNA transcribed in vitro containing a
40 bp target of EV71 VP1. The amount of RNA was quantiﬁed
sing a spectrophotometer (NanoDrop2000, ThermoFisher Scien-
iﬁc, Ohio, USA). The number of copies of RNA was calculated
sing the following formula (Ke et al., 2006): Y (molecules/l) = X
g/l) (nucleotide length × 340) × 6.02 × 1023. The concentration
f the initial synthesized positive control RNA was  2 × 1011. The
ositive control RNA was diluted to 105 copies per reaction and
0-fold serial dilutions of the RNA were generated to evaluate
he technical sensitivity of SAT-EV71. The endpoint sensitivity of
AT-EV71 and PCR-ﬂuorescence probing assay for EV71 was  esti-
ated using 10-fold serial dilutions of the EV71 strain (genotype
4). The cultured EV71 strain had original titer of 4.0 × 106 median
issue culture infective dose (TCID50)/mL. The TCID50 value was
alculated by the Reed-Müench method (Burleson et al., 1992).
AT-EV71 assay speciﬁcity was evaluated by its ability to test 12
igh-titer virus stock solutions containing 9 different enterovirus
trains related to HFMD, including EV71, and 3 nonenterovirus
trains.
To evaluate the repeatability and reproducibility of SAT-EV71,
wo different dilutions of EV71 RNA (105 and 103 copies per reac-
ion) were tested respectively.
Each dilution was tested 20 times by the same operator in
he same laboratory for the assessment of repeatability. As for
he reproducibility, each dilution was analyzed ﬁve times by
ig. 2. SAT-EV71 could successfully amplify from 105 to 101 copies per reaction of the po
f  IC RNA (5000 copies per reaction).ith red color. (For interpretation of the references to color in this text, the reader is
two different operators on different ﬁve days in two different
laboratories.
2.5. PCR-ﬂuorescence probe assay for EV71
The PCR-ﬂuorescence probe assay of EV71 was  assessed using
EV71 PCR-Fluorescence Diagnostic Kits (DaAn Gene Corporation,
Guangzhou, China) and a 7500 real-time PCR system (Applied
Biosystems Corporation, USA). EV71 VP1 served as the detected
target gene. The cycling conditions were based on those provided
in the manufacturer’s instructions: 15 min  at 50 ◦C, 15 min  at 95 ◦C,
and 45 cycles of 15 s at 94 ◦C and 45 s at 55 ◦C. The results were
considered positive when Ct values were below 38.
2.6. Application of SAT-EV71 in clinical specimens
The sensitivity and speciﬁcity of SAT-EV71 were also evaluated
using 256 clinical specimens, of which 196 results were compared
with those of a PCR-ﬂuorescence probing assay and 60 results with
those of virus-cell culture method. 40 of the 60 throat swabs were
identiﬁed as EV71-positive and 20 as CA16-positive. Sequencing
analysis was  used on specimens with inconsistent results of SAT
and PCR-ﬂuorescence probing assay.
2.7. Statistical analysisStatistical data analyses were performed using the SPSS 17.0
package for Windows (SPSS Corporation, Illinois, USA). The
results of the SAT-EV71 and PCR-ﬂuorescence probing assay were
sitive control RNA containing a 140 bp target of EV71 VP1 with the optimal amount
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Fig. 3. Comparison of sensitivity of SAT-EV71 and PCR-ﬂuorescence probing assay
for  EV71 using EV71 virus strains. (A). SAT-EV71 was able to amplify EV71 virus
642 Q. Chen et al. / Journal of Virolo
ompared using the test for robust assessment (kappa coefﬁcient).
he kappa coefﬁcient was calculated for any comparison in which
he value of all data cells was ≥3. Kappa values ≥0.75 were taken
o indicate good agreement (Ali et al., 2011).
. Results
.1. Sensitivity of SAT-EV71
The technical limit in detection of SAT-EV71 was assessed using
0-fold serial dilutions of the positive control RNA containing a
40 bp target of EV71 VP1. SAT-EV71 was found to successfully
mplify from 105 to 101 copies per reaction when the optimal
mount of IC, 5000 copies per reaction, was used (Fig. 2). To
ompare the sensitivity of the two assays, SAT-EV71 and PCR-
uorescence probing assay were assessed down to 0.01 and 0.1
CID50 per reaction, respectively (Fig. 3). The SAT-EV71 assay
ppeared more sensitive than PCR-ﬂuorescence probing assay for
V71.
.2. Speciﬁcity of SAT-EV71
The speciﬁcity of the SAT-EV71 assay was evaluated in terms
f its ability to detect high-titer virus stock solutions of different
iral strains. The EV71 strain was ampliﬁed successfully. In contrast,
nterovirus strains other than EV71 and non-human enterovirus
trains (107 copies) produced no positive signals (data not shown).
he results indicated that the SAT-EV71 was highly speciﬁc to EV71
nd produced no cross-reactions. The speciﬁcity of the SAT-EV71
as found to be unaffected by the addition of IC RNA (5000 copies).
.3. Repeatability and reproducibility of SAT-EV71
The repeatability and reproducibility of SAT-EV71 were assessed
y calculation of the coefﬁcient of variation (CV) in the thresh-
ld cycle (Ct) of the positive ampliﬁcation curves, which Ct values
ere regressed to generate a predicted amount of target RNA. The
Vs were 4.4% and 3.6% respectively in a single run of the two dif-
erent dilutions (105 and 103 copies per reaction) (repeatability);
hile, the CVs were 2.9% and 1.7% respectively in different runs
reproducibility), indicating that SAT-EV71 was satisfactory.
.4. SAT-EV71 in clinical specimens
In the 60 throat swabs veriﬁed by virus-cell culture method,
V71 was successfully ampliﬁed by SAT-EV71 from all EV71-
ositive throat swabs, rather than CA16-positive swabs. The
ensitivity and speciﬁcity of SAT-EV71 were also compared with
he PCR-ﬂuorescence probe assay with respect to 196 clinical
amples from putative HFMD patients. The results of the com-
arison are shown in Table 2. In the SAT-EV71 system, IC RNA
as added to ensure the successful extraction and ampliﬁcation.
wo samples had been classiﬁed as false negatives regardless
f negative IC results. When another aliquot of the two spec-
mens with negative IC results were retested, IC ampliﬁcations
ere observed. They were classiﬁed as positive based on the sec-
nd results. The positive rate of SAT-EV71 increased from 46.4%
91/196) to 47.4% (93/196) in consideration of the IC results.
one of the samples which were positive by PCR-ﬂuorescence
robing assay was found to be negative by SAT-EV71. Only four
amples positive by SAT-EV71 were found to be negative by PCR-
uorescence probing. The statistically robust assessment of both
ssays reached 98.0% (192/196), with a kappa value of 0.96, con-
rming good agreement between SAE-EV71 and PCR-ﬂuorescencestrain from 10 TCID50 to 0.01 TCID50. (B) PCR-ﬂuorescence probing assay for EV71
could only amplify EV71 virus strain from 106 TCID50 to 0. 1 TCID50, which was  10
times lower than SAT-EV71.
probing assay with respect to the analysis of the 196 clinical
samples.
3.5. Resolution of discrepancies
The SAT products of the four samples that showed inconsis-
tent results were sequenced by Invitrogen Corporation (Shanghai,
China). Sequence information was  successfully collected from three
of those four samples. The BLAST program was used to analyze
the VP1 sequences of the three samples. They showed complete
homology to the VP1 sequences of different EV71 strains in Nanjing,
speciﬁcally JN944891.1, JN944857.1, and JN944855.1. DNASTAR
software was  used to distinguish the three samples’ nucleotide
sequences, suggesting that they shared highly homology. The
sequences of two samples were identical and another one differed
from the other two by only two  bases, as exhibited in Fig. 4. The
Q. Chen et al. / Journal of Virological Methods 196 (2014) 139– 144 143
Table 2
Performances of the SAT-EV71 and PCR-ﬂuorescence probing assay in clinical specimens.a
SAT-EV71 regardless of IC SAT-EV71 considering IC
Negative Positive Overall Rate Negative Positive Overall Rate
PCR-ﬂuorescence
probing assay
Negative 105 4 109 55.6% 103 4 107 54.6%
Positive 0 87 87 44.4% 0 89 89 45.4%
Overall 105 91 196 103 93 196
Rate 46.4% 47.4%
a A total of 196 clinical throat swabs were obtained from 196 suspicious HFMD patients registered in Nanjing Children’s Hospital afﬁliated to Nanjing Medical University
within 2–5 days after the onset of infection.
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fig. 4. Nucleotide sequence analysis of EV71 VP1 about three samples with discor
abeled  with red color). (For interpretation of the references to color in this text, the
equencing results of the three samples were completely consis-
ent with the results of SAT-EV71. The discharge diagnoses of the
our juvenile patients were HFMD, conﬁrming that the results of
AT-EV71 were accurate.
. Discussion
The SAT-EV71 method was developed to improve the rate of
etection of EV71, which was based on isothermal ampliﬁcation
f RNA and real-time ﬂuorescence detection of EV71. Brieﬂy, EV71
P1 was reverse-transcribed using M-MLV  reverse transcriptase to
enerate a 140 bp DNA fragment with a pair of speciﬁc primers.
hese primers contained the T7 promoter in the forward primer.
he DNA was then transcribed into RNA using T7 RNA polymerase
o allow successive cycles of ampliﬁcation. A probe labeled with
AM at the 5′ end and DABCYL at the 3′ end was  included. This
robe released a ﬂuorescent signal when hybridized with the target
NA. Kinetic measurements of the real-time ampliﬁcation ﬂuo-
escent signal were detected using real-time PCR equipment, as
reviously described by Cui et al. (2012). Cui et al. (2012) estab-
ished SAT-TB to detect the M.  tuberculosis complex, which has been
roven to be rapid, sensitive, and speciﬁc. Nakajima et al. (2012)
eveloped a transcription–reverse transcription concerted reaction
TRCR) method to test for EV71. The TRCR method has also been
ndicated to be highly speciﬁc, sensitive and rapid (Tanaka et al.,
010; Nakajima et al., 2012); however, TRCR is end-point detec-
ion which requires specialized equipment. The SAT method is a
eal-time detection using routine real-time PCR equipment, which
s common in most clinical labs. For the detection procedure of SAT-
V71, there was no need to open the reaction tube lid, with the risk
f contamination being minimized. M-MLV  reverse transcriptase,
ifferent from TRCR, was used in SAT method.
Multiple genotypes of EV71 have been found circulating in Asian
ountries and regions, such as Japan, Malaysia and Taiwan. How-
ver, Xu, et al. reported that C4 genotype strain of EV71 had been
he only predominant strain in mainland China for more than 14
ears since 1998 (Zhang et al., 2013). Based on the above results, C4
enotype of EV71 was selected as the strain to assess the sensitivity
f SAT-EV71 in this study. SAT-EV71 was proved to be slightly more
ensitive than EV71-PCR-ﬂuorescence probing assay when testing
or the EV71 virus strain (genotype C4).esults by the SAT-EV71 and PCR-ﬂuorescence probing assay (different bases were
er is referred to the web version of the article.)
In the present study, the whole ampliﬁcation reaction of SAT-
EV71 took place in only 1 h, making it only about half the time
period of the EV71-speciﬁc PCR-ﬂuorescence probing assay. The
results for 60 throat swabs tested by SAT-EV71 were identi-
cal to those of the cell culture method. No sample positive by
PCR-ﬂuorescence probing assay was negative by SAT-EV71. The
four samples with inconsistent results were all positive based on
sequencing analysis and clinical diagnosis. It demonstrated a high
sensitivity of SAT-EV71 in testing clinical situations. The symptoms
of EV71 and CA16 infections are similar, which makes them difﬁcult
to distinguish from HFMD in clinical settings. SAT-EV71 was found
to distinguish between EV71 and CA16 with no cross-reaction,
demonstrating the SAT-EV71 had high level of speciﬁcity.
Extracted clinical specimens may  contain substances that
inhibit enzyme-based nucleic acid ampliﬁcation. For this reason,
IC is used to monitor nucleic acid extraction and ampliﬁcation to
assure that specimens are successfully detected (Rosenstraus et al.,
1998). Positive IC results suggest that ampliﬁcation has occurred,
thus conﬁrming that negative test results are truly negative. In this
way, IC increases the sensitivity of the assay, which a few studies
have indicated (Rosenstraus et al., 1998; Xiao et al., 2009; Sidoti
et al., 2012). Present literature about RT-LAMP for EV71 could not
rule out possible false negative results due to lack of IC (Jiang et al.,
2011; Shi et al., 2011; Xia et al., 2011; Wang et al., 2012; Yaqing
et al., 2012). One false-negative result of SAT-TB was  reported by
Cui et al. (2012), which indicated the presence of inhibitors of
enzymatic ampliﬁcation, suboptimal target extraction, or uneven
distribution of mycobacteria in the sample. Cui suggested that the
diagnostic accuracy of SAT-TB could be improved by the addition
of an internal control. In this study, IC was used to monitor all SAT-
EV71 assay results. All the negative results were validated through
observation of the ampliﬁcations of IC, including two retested sam-
ples. In this way, IC increased the SAT-EV71 assay’s sensitivity.
5. Conclusions
The SAT-EV71 with IC developed in this study was  found to be
highly speciﬁc and sensitive in the detection of EV71 from clin-
ical specimens. The use of IC prevented false negative readings
and improved accuracy of the assay. SAT- EV71 may  meet the
demand for a means of detecting EV71 in outbreak situations more
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ffectively than other current nucleic acid ampliﬁcation tech-
iques, such as real-time RT-PCR and RT-LAMP.
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